-
RESEARCHERS at MIT have developed a new computer model which can help increase the shelf life of drugs made of antibodies.
30/06/2009 |
-
CLEMEX Technologies is creating a new division which will develop medical instruments for haematology and pathology applications.
30/06/2009 |
-
NOBEL Prize winning immunologist Professor Jean Dausset has died age 92.
29/06/2009 |
-
THE 28 June online edition of Nature Biotechnology has published a study on a method to detect and quantify multiple protein biomarkers in blood samples.
29/06/2009 |
-
BIOMEDICAL researchers from Monash University and the University of Melbourne are developing peptides as vaccines against melanoma.
25/06/2009 |
-
RESEARCHERS at the University of Massachusetts Amherst have developed a ‘chemical nose’ array of nanoparticles and polymers to detect cancer earlier.
25/06/2009 |
-
CYTOPIA has filed an Investigational New Drug Application with the US Food and Drug Administration for its orally active JAK2 inhibitor CYT387.
24/06/2009 |
-
LIVING Cell Technologies says New Zealand has authorised the Phase I/IIa clinical trial of DIABECELL for insulin dependent diabetes.
24/06/2009 |
-
CIRCADIAN has been granted a key strategic patent for the exclusive use of the VEGF-D protein and VEGF-D antibodies in Europe for angiogenic applications.
23/06/2009 |
-
MICROSOFT has announced the winners of its 2009 Microsoft Pharmaceutical and Life Sciences Innovation Awards.
23/06/2009 |
-
BIOTEK has announced the expansion of its gold-standard ELx405 Microplate Washer product line with the introduction of the ELx405 Magnetic Bead Washer
16/06/2009 |
-
THE LIFE Technologies Foundation has announced it has awarded $2m to three grant recipients working to advance life science, including the University of North Texas for DNA-PROKIDS, the New York Academy of Sciences and the Science Museum in London.
16/06/2009 |
-
DIFFERENCES in the DNA among Mexico’s 65 ethnic populations must be identified to significantly advance that developing nation’s public health.
12/06/2009 |
-
SIGMA-Aldrich has announced the launch of its Services Network which has been designed to provide laboratory services for the pharmaceutical and biotechnology industry.
10/06/2009 |
-
PEPLIN has announced the initiation of two Phase III clinical trials to confirm the efficacy and safety of PEP005 (ingenol mebutate) Gel for the treatment of actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, when applied to head locations includuing the face and scalp
10/06/2009 |
-
MERCK KGaA has released follow-up safety data from a randomized Phase IIb study of patients with inoperable advanced (stage IIIb/IV) non-small cell lung cancer (NSCLC).
10/06/2009 |
-
A NEW study undertaken by researchers at Monash University, has shown the overall incidence of cancer among Queensland’s fire fighters is no higher than expected when compared to the general Queensland population.
05/06/2009 |
-
PROFESSOR Chris O’Brien, Australia’s foremost head and neck surgeon has lost his fight with fight with brain cancer aged 57.
05/06/2009 |
-
THE UNITED Kingdom’s National Institute for Health and Clinical Excellence (NICE) has released a Final Appraisal Determination recommending the use of the drug Erbitux (cetuximab) in combination with chemotherapy as a first-line treatment for patients with metastatic colorectal cancer (mCRC).
04/06/2009 |
-
AUSTRALIAN researchers at the CSIRO Preventative Health National Research into Colorectal Cancer and Gut Health, Flinders University and Clinical Genomics have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.
04/06/2009 |
-
BAYER Schering Pharma has announced the results of Phase I and II trials of BAY 73-4506 an oral multi-kinase inhibitor currently being studied in multiple tumour types.
03/06/2009 |
-
APPLIED Biosystems has announced scientists at bioMérieux and the Institute of Analytical Sciences of the University of Lyon in France are collaborating to advance the discovery of biomarkers used to diagnose or monitor disease.
03/06/2009 |
-
VARIAN Medical Systems has announced it will be demonstrating its full range of brachytherapy cancer treatment equipment and software at the American Brachytherapy Society meeting in Toronto, Canada, from 31 May to 2 June 2009
03/06/2009 |
-
RESEARCH in Queensland has been given a boost with the opening of three new facilities which will be used in the study of plastic made from sugarcane, nano-chips to speed up computers and new DNA based bio-medicines.
01/06/2009 |